MarketPeel
Insider Trading Intelligence
BG

Bruce Greenberg

ALDX
SEE REMARKS · ALDEYRA THERAPEUTICS, INC. · CIK 0001928391
FILING MIX · LIFETIME33%/67%
BUYS
2
SELLS
4
TOTAL VALUE
$141.2K
COMPANIES
1
ACTIVE SINCE
Jul 2022
HOLDINGS NOW
126,382
AVG SELL PX
$3.79
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Bruce Greenberg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%-0.49%+2.78%-3.27%-3.27%
14d2+50.00%+1.57%+3.57%-2.00%-2.00%
30d2+0.00%+30.54%+2.42%+28.13%+28.13%
60d2+0.00%+14.53%+5.60%+8.92%+8.92%
90d2+0.00%+17.33%+8.86%+8.47%+8.47%
180d2+0.00%+56.73%+9.87%+46.86%+46.86%
1y2+0.00%+62.88%+15.89%+46.99%+46.99%
2y2(1 pending)+0.00%+52.00%+34.38%+17.62%+17.62%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALDX · 126,382 shares · as of Aug 12, 2024
063,070126,140189,210252,28020232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
FLOW · 2 buys / 4 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
See Remarks
10,834$4.74$51.3K126,382Aug 12, 2024Aug 14, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
See Remarks
13,201$3.41$45.0K130,154Mar 11, 2024Apr 17, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALE
See Remarks
13,201$3.41$45.0K120,699Mar 11, 2024Mar 12, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
252,280252,280Mar 9, 2024Mar 12, 2024View →
ALDX
ALDEYRA THERAPEUTICS, INC.
SALEGRANT
Stock grant
110,028110,028Feb 28, 2023Mar 2, 2023View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
126,087133,900Jul 15, 2022Jul 19, 2022View →
Other insiders · ALDX
Loading peer insiders…
About this filer
CIK 0001928391
ROLE
See Remarks
PRIMARY
ALDX
COMPANIES
1
ACTIVE SINCE
Jul 2022
MARKETPEEL · /INSIDER/0001928391DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback